Article

Functional and microstructural changes in eyes of patients with MS

Patients with multiple sclerosis (MS) but not optic neuritis may have functional ocular impairments from chronic axonal loss, according to Güngö r Sobaci, MD, from Ankara, Turkey, reporting at the American Academy of Ophthalmology annual meeting.

Patients with multiple sclerosis (MS) but not optic neuritis may have functional ocular impairmentsfrom chronic axonal loss, according to Güngör Sobaci, MD, from Ankara, Turkey, reportingat the American Academy of Ophthalmology annual meeting.

Dr. Sobaci pointed out that the retina provides a unique model of neurodegeneration. He is from theGülhane Military Medical Academy and Medical School in Ankara.

Thirty-two patients from one center and 37 controls were included in this study (19 men, 13 women;mean age, 35.6 years).

Dr. Sobaci reported that the retinal nerve fiber layer thickness was significantly thinner inpatients with MS compared with controls (68.1 µm versus 79.1 µm, respectively;p = 0.001). The retinal nerve fiber layer temporally was thinner in patients with MS comparedwith controls (p = 0.017). The central macular thickness was also thinner in MS (188.2 µmversus 203.2 µm, respectively; p = 0 .02). There was a significant difference in the P100latency value. The mean stereoacuity was 83.5 arc sec in the patients with MS compared with 22.8 arcsec in controls (p

Dr. Sobaci said, "The retinal nerve fiber layer thickness may be an objective assessment of ocularchanges in patients with MS."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.